Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes

George U. Eleje, Euzebus C. Ezugwu, Ifeanyichukwu U. Ezebialu, Nnabuike O. Ojiegbe, Richard O. Egeonu, Chukwudi C. Obiora, Chigozie G. Okafor, Joseph I. Ikechebelu, Ahizechukwu Eke

Research output: Contribution to journalArticle

Abstract

Objective: To compare AmnioQuick Duo+ versus the placental α-microglobulin-1 (PAMG-1) test for diagnosis of prolonged premature rupture of membranes (PROM). Methods: A multicenter prospective cohort study included women with suspected PROM at six tertiary institutions in southern Nigeria between January 1 and December 31, 2015. The inclusion criteria were features of PROM lasting at least 24 hours and a pregnancy duration of more than 24 weeks. AmnioQuick Duo+ (Biosynex, Strasbourg, France) and PAMG-1 (AmniSure International, Boston, USA) tests were used to diagnose PROM, which was confirmed after delivery by any two of the following criteria: delivery within 48 hours to 7 days, chorioamnionitis, membranes perceptibly ruptured at delivery, and adverse perinatal outcomes considerably associated with prolonged PROM. Results: Of 100 women assessed for eligibility, 99 were included. Sensitivity, specificity, and accuracy were, respectively, 97.3%, 100%, and 95.9% for AmnioQuick Duo+, and 93.2%, 100%, and 90.4% for PAMG-1. The differences were not significant and the diagnostic discordant rate between the two tests was 3.1%. In equivocal cases (i.e., negative pooling test result), AmnioQuick Duo+ and PAMG-1 performed equally (diagnostic accuracy, 100% vs 97.7%; P>0.99). Conclusion: For diagnosis of PROM, AmnioQuick Duo+ was found to be non-inferior and comparable in accuracy to the PAMG-1 test, with a diagnostic discordance rate of 3.1%.

Original languageEnglish (US)
Pages (from-to)180-186
Number of pages7
JournalInternational Journal of Gynecology and Obstetrics
Volume144
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Rupture
Membranes
Chorioamnionitis
Nigeria
France
Cohort Studies
Prospective Studies
Sensitivity and Specificity
Pregnancy

Keywords

  • Accuracy
  • AmnioQuick Duo+
  • Equivocal
  • PAMG-1
  • Prolonged
  • PROM

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes. / Eleje, George U.; Ezugwu, Euzebus C.; Ezebialu, Ifeanyichukwu U.; Ojiegbe, Nnabuike O.; Egeonu, Richard O.; Obiora, Chukwudi C.; Okafor, Chigozie G.; Ikechebelu, Joseph I.; Eke, Ahizechukwu.

In: International Journal of Gynecology and Obstetrics, Vol. 144, No. 2, 01.02.2019, p. 180-186.

Research output: Contribution to journalArticle

Eleje, George U. ; Ezugwu, Euzebus C. ; Ezebialu, Ifeanyichukwu U. ; Ojiegbe, Nnabuike O. ; Egeonu, Richard O. ; Obiora, Chukwudi C. ; Okafor, Chigozie G. ; Ikechebelu, Joseph I. ; Eke, Ahizechukwu. / Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes. In: International Journal of Gynecology and Obstetrics. 2019 ; Vol. 144, No. 2. pp. 180-186.
@article{336f870bc5664e9b903c15e60f156acd,
title = "Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes",
abstract = "Objective: To compare AmnioQuick Duo+ versus the placental α-microglobulin-1 (PAMG-1) test for diagnosis of prolonged premature rupture of membranes (PROM). Methods: A multicenter prospective cohort study included women with suspected PROM at six tertiary institutions in southern Nigeria between January 1 and December 31, 2015. The inclusion criteria were features of PROM lasting at least 24 hours and a pregnancy duration of more than 24 weeks. AmnioQuick Duo+ (Biosynex, Strasbourg, France) and PAMG-1 (AmniSure International, Boston, USA) tests were used to diagnose PROM, which was confirmed after delivery by any two of the following criteria: delivery within 48 hours to 7 days, chorioamnionitis, membranes perceptibly ruptured at delivery, and adverse perinatal outcomes considerably associated with prolonged PROM. Results: Of 100 women assessed for eligibility, 99 were included. Sensitivity, specificity, and accuracy were, respectively, 97.3{\%}, 100{\%}, and 95.9{\%} for AmnioQuick Duo+, and 93.2{\%}, 100{\%}, and 90.4{\%} for PAMG-1. The differences were not significant and the diagnostic discordant rate between the two tests was 3.1{\%}. In equivocal cases (i.e., negative pooling test result), AmnioQuick Duo+ and PAMG-1 performed equally (diagnostic accuracy, 100{\%} vs 97.7{\%}; P>0.99). Conclusion: For diagnosis of PROM, AmnioQuick Duo+ was found to be non-inferior and comparable in accuracy to the PAMG-1 test, with a diagnostic discordance rate of 3.1{\%}.",
keywords = "Accuracy, AmnioQuick Duo+, Equivocal, PAMG-1, Prolonged, PROM",
author = "Eleje, {George U.} and Ezugwu, {Euzebus C.} and Ezebialu, {Ifeanyichukwu U.} and Ojiegbe, {Nnabuike O.} and Egeonu, {Richard O.} and Obiora, {Chukwudi C.} and Okafor, {Chigozie G.} and Ikechebelu, {Joseph I.} and Ahizechukwu Eke",
year = "2019",
month = "2",
day = "1",
doi = "10.1002/ijgo.12703",
language = "English (US)",
volume = "144",
pages = "180--186",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Performance indices of AmnioQuick Duo+ versus placental α-microglobulin-1 tests for women with prolonged premature rupture of membranes

AU - Eleje, George U.

AU - Ezugwu, Euzebus C.

AU - Ezebialu, Ifeanyichukwu U.

AU - Ojiegbe, Nnabuike O.

AU - Egeonu, Richard O.

AU - Obiora, Chukwudi C.

AU - Okafor, Chigozie G.

AU - Ikechebelu, Joseph I.

AU - Eke, Ahizechukwu

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Objective: To compare AmnioQuick Duo+ versus the placental α-microglobulin-1 (PAMG-1) test for diagnosis of prolonged premature rupture of membranes (PROM). Methods: A multicenter prospective cohort study included women with suspected PROM at six tertiary institutions in southern Nigeria between January 1 and December 31, 2015. The inclusion criteria were features of PROM lasting at least 24 hours and a pregnancy duration of more than 24 weeks. AmnioQuick Duo+ (Biosynex, Strasbourg, France) and PAMG-1 (AmniSure International, Boston, USA) tests were used to diagnose PROM, which was confirmed after delivery by any two of the following criteria: delivery within 48 hours to 7 days, chorioamnionitis, membranes perceptibly ruptured at delivery, and adverse perinatal outcomes considerably associated with prolonged PROM. Results: Of 100 women assessed for eligibility, 99 were included. Sensitivity, specificity, and accuracy were, respectively, 97.3%, 100%, and 95.9% for AmnioQuick Duo+, and 93.2%, 100%, and 90.4% for PAMG-1. The differences were not significant and the diagnostic discordant rate between the two tests was 3.1%. In equivocal cases (i.e., negative pooling test result), AmnioQuick Duo+ and PAMG-1 performed equally (diagnostic accuracy, 100% vs 97.7%; P>0.99). Conclusion: For diagnosis of PROM, AmnioQuick Duo+ was found to be non-inferior and comparable in accuracy to the PAMG-1 test, with a diagnostic discordance rate of 3.1%.

AB - Objective: To compare AmnioQuick Duo+ versus the placental α-microglobulin-1 (PAMG-1) test for diagnosis of prolonged premature rupture of membranes (PROM). Methods: A multicenter prospective cohort study included women with suspected PROM at six tertiary institutions in southern Nigeria between January 1 and December 31, 2015. The inclusion criteria were features of PROM lasting at least 24 hours and a pregnancy duration of more than 24 weeks. AmnioQuick Duo+ (Biosynex, Strasbourg, France) and PAMG-1 (AmniSure International, Boston, USA) tests were used to diagnose PROM, which was confirmed after delivery by any two of the following criteria: delivery within 48 hours to 7 days, chorioamnionitis, membranes perceptibly ruptured at delivery, and adverse perinatal outcomes considerably associated with prolonged PROM. Results: Of 100 women assessed for eligibility, 99 were included. Sensitivity, specificity, and accuracy were, respectively, 97.3%, 100%, and 95.9% for AmnioQuick Duo+, and 93.2%, 100%, and 90.4% for PAMG-1. The differences were not significant and the diagnostic discordant rate between the two tests was 3.1%. In equivocal cases (i.e., negative pooling test result), AmnioQuick Duo+ and PAMG-1 performed equally (diagnostic accuracy, 100% vs 97.7%; P>0.99). Conclusion: For diagnosis of PROM, AmnioQuick Duo+ was found to be non-inferior and comparable in accuracy to the PAMG-1 test, with a diagnostic discordance rate of 3.1%.

KW - Accuracy

KW - AmnioQuick Duo+

KW - Equivocal

KW - PAMG-1

KW - Prolonged

KW - PROM

UR - http://www.scopus.com/inward/record.url?scp=85056799662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056799662&partnerID=8YFLogxK

U2 - 10.1002/ijgo.12703

DO - 10.1002/ijgo.12703

M3 - Article

VL - 144

SP - 180

EP - 186

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 2

ER -